All articles tagged: Parkinson's disease (G20)

Gait and tremor measures derived from a commercially available smartwatch and smartphone could help evaluate the efficacy of therapies for Parkinson disease (PD), according to a study published online June 12 in npj: Parkinson's Disease.Jamie L. Adams, M.D., from the University of Rochester Medical Center in New York, and colleagues exa

The article suggests Parkinson's disease may stem from environmental toxins inhaled into the brain's smell center or ingested through the gut. It emphasizes the importance of understanding and preventing exposure to such toxins to combat not only Parkinson's but also other brain disorders like ALS and Alzheimer's.

The Allen Institute, founded by Paul Allen in 2003, embarked on an ambitious mission to map the 86 billion neurons of the human brain. This endeavor aims to decode the intricate workings of the brain and provide insights into various neurological diseases.

High-intensity exercise may reverse Parkinson's neurodegeneration, preserving dopamine neurons, with brain imaging showing improved health after six months. It's crucial for managing Parkinson's, potentially offering neuroprotective benefits beyond medication, but more research is needed for a full understanding.

UW-Madison scientists created 3D-printed brain tissue mimicking normal function, aiding research on disorders like Alzheimer's. They horizontally layered neurons in a soft gel, enabling communication and network formation resembling human brains, offering a precise and accessible technique for studying brain conditions and drug testing.

Pickleball's escalating popularity comes with a steep rise in injuries, estimated to cost the US medical system a substantial $377 million in 2023 alone. This surge in injuries, however, is being viewed as an opportunity by some healthcare providers. Rather than just reacting to the problem, they are forging partnerships with pickleball organizations to proactively address injury prevention and ca

The article discusses Neuralink, a company founded by Elon Musk, and explores the science behind it. It covers Neuralink's brain-machine interface technology and its potential applications in medical and human enhancement fields. It also touches upon the challenges and ethical considerations associated with this emerging technology.

For patients with Parkinson disease (PD), differences in quality of life (QOL) outcomes are seen with deep brain stimulation of the subthalamic nucleus (STN-DBS), according to a study published online Jan. 18 in JAMA Network Open.Stefanie T. Jost, Ph.D., from the University of Cologne in Germany, and colleagues examined the long-term ef

Cardiac 18F-dopamine positron emission tomography (PET) can identify at-risk individuals who are subsequently diagnosed with a central Lewy body disease (LBD), according to a study published online Oct. 26 in the Journal of Clinical Investigation.David S. Goldstein, M.D., Ph.D., from the National Institutes of Health in Be

The US EPA has proposed a ban on trichloroethylene (TCE), a cancer-causing chemical used in manufacturing. This move aims to address health concerns linked to TCE exposure, including liver damage and Parkinson's disease. The ban would be phased in over time, starting with consumer products within a year.